Liid Pharmaceuticals, Inc.
PrivateLast Round
Grant
Jan 13, 2026
Est. Valuation
$7.89M
Total Funding Raised
$2.73M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Liid Pharmaceuticals, Inc. operates in Healthcare & Life Sciences and is based in Suita. Its latest recorded funding round was a Grant round in January 2026.
Liid Pharmaceuticals, Inc. is a biotechnology company that develops antisense oligonucleotide therapeutics using its proprietary BROTHERS technology platform to treat intractable diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Liid Pharmaceuticals, Inc. Comparables
Compare Liid Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rena Therapeutics Inc. | 83% | |
| Luxna Biotech Co., Ltd. | 81% | |
| TKG Therapeutics, Inc. | 78% |
For institutional investors. Book with your work email.
Liid Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 13, 2026 | ||||
| VC Round | Apr 26, 2024 | ||||
| Seed | Oct 26, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Liid Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Energy and Industrial Technology Development Organization | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 452% MoM.
- Jan 13, 2026
$1.86M grant from New Energy and Industrial Technology Development Organization.
For institutional investors. Book with your work email.
Liid Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Liid Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is Liid Pharmaceuticals, Inc. a public or private company?
Liid Pharmaceuticals, Inc. is a private company.
What is the current stock price of Liid Pharmaceuticals, Inc.?
Liid Pharmaceuticals, Inc. is a private company, so its shares have no public market price. Caplight tracks Liid Pharmaceuticals, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Liid Pharmaceuticals, Inc. worth (valuation)?
Liid Pharmaceuticals, Inc.'s valuation is estimated at $7.9M based on funding round data.
Can I buy Liid Pharmaceuticals, Inc. stock?
Liid Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Liid Pharmaceuticals, Inc.'s last funding round?
Liid Pharmaceuticals, Inc.'s most recent funding round was Grant on January 13, 2026.
Who are the main investors in Liid Pharmaceuticals, Inc.?
Key investors in Liid Pharmaceuticals, Inc. include New Energy and Industrial Technology Development Organization.
Will Liid Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for Liid Pharmaceuticals, Inc..
How can I track Liid Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Liid Pharmaceuticals, Inc.'s shares on secondary markets.